UK Markets open in 6 hrs 11 mins

Cyteir Therapeutics, Inc. (CYT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.61+0.19 (+1.16%)
At close: 04:00PM EST
16.61 0.00 (0.00%)
After hours: 04:00PM EST
Currency in USD

Valuation measures

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 323.10
52-week low 313.67
50-day moving average 316.99
200-day moving average 318.10

Share statistics

Avg vol (3-month) 3115.82k
Avg vol (10-day) 324.23k
Shares outstanding 534.47M
Implied shares outstanding 6N/A
Float 810.07M
% held by insiders 14.27%
% held by institutions 157.42%
Shares short (14 Oct 2021) 42.52M
Short ratio (14 Oct 2021) 413.48
Short % of float (14 Oct 2021) 410.69%
Short % of shares outstanding (14 Oct 2021) 47.11%
Shares short (prior month 14 Sept 2021) 41.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-16.59M
EBITDA -28.65M
Net income avi to common (ttm)-29M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)198.64M
Total cash per share (mrq)5.68
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)26.91
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-23.23M
Levered free cash flow (ttm)N/A